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Neonatal skin grafts have the capacity to outlive adult 
skin grafts, especially in situations involving H-2 antigen 
compatibility of donor and host. Neonatal grafts can 
induce a state of tolerance in their hosts; in many cases, 
recipients exposed to neonatal allografts fail to reject 
adult grafts from the same donor strain. 
In the H-2 antigen compatible C3H - CBA combina-
tion, survival of neonatal skin grafts is correlated with 
the emigration of passenger leukocytes from the graft 
vasculature. Removal of a neonatal C3H skin graft has 
no effect on the unresponsive state of the host with 
respect to subsequent grafts of adult tissue. Donor leu-
kocytes are present in various tissues of the tolerant 
CBA host, and treatments (such as irradiation) that elim-
inate the normal leukocytic population of a neonatal 
C3H skin graft also eliminate the likelihood of skin graft 
survival and block the establishment of tolerance. 
In the C57BL/6 (B6) male-to-female system, survival 
of neonatal skin grafts is not correlated with emigration 
of passenger cells. Removal of a neonatal male B6 graft 
breaks the tolerance of the female host. The tolerant 
female is not a leukocyte chimera, and irradiation of the 
neonatal graft or replacement of the passenger cells with 
adult male cells does not eliminate the likelihood of graft 
survival nor does it block the establishment of tolerance. 
Moreover, passenger cells play no part in tolerance to 
Sk antigen incompatible grafts; Sk (skin-specific) anti-
gens do not occur in lymphocytes. 
The anomalous survival of neonatal skin grafts, evi-
dently promoted by different mechanisms in different 
donor-host combinations, remains to be clarified. And it 
remains also to be determined whether the idiosyncratic 
performance of certain neonatal passenger cells has any 
physiological relevance. 
Genes that determine the presence of antigenic cell mem-
brane components are called histocompatibility genes (H 
genes). The cell surface components are called histocompati-
bility antigens (in the mouse: H-1, H-2, H-3, etc.). A single 
"foreign" H antigen in a graft usually elicits in the host an 
immune response culminating in rejection of the graft. The 
speed of rejection is functionally related to the "strength" and 
number of H genes differing in donor and host. Weak genetic 
differences between donor and host are associated with chronic 
rejection, and strong differences with rapid rejection. 
In every mammalian species there is a major histocompati-
bility complex (MHC), including genetic loci that determine 
formation of strong H antigens causing allograft reactions of 
maximal intensity. Consider, for example, the MHC of the 
mouse, H-2. Skin allografts exchanged between H-2 antigen 
incompatible donor and host almost invariably ru·e rejected 
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within 2 wk (often within 8 or 9 days). In contrast, grafts 
exchanged between animals with the same H -2 allele are re-
jected more slowly; these grafts may survive for 2 wk to more 
than 18 mo; the time of survival depends on the degree of 
"minor" immunogenetic disparity between the donor and host. 
An unusual situation is encountered when the donor is a 
newborn or fetal animal (reviewed in reference 1). In cases of 
minor histoincompatibility, skin grafts from newborn or fetal 
donors often survive, while genetically " identical" grafts from 
adult donors ru·e destroyed. In fact, perinatal grafts may r ender 
their hosts unresponsive to subsequent (or simultaneous) grafts 
of adult tissue. 
In this article, I shall review a series of studies, performed in 
collaboration with my teacher, Willys K. Silvers of the Univer-
sity of Pennsylvania, showing that, in certai,p cases, the "privi-
lege" extended to newborn or fetal grafts may be due to th e 
emigration of passenger leukocytes from the graft vasculature. 
MATERIALS AND METHODS 
The methods employed are standard; they are summarized below. 
Animals 
We used the following inbred strains and their F, hybrids: A/ Ss (A); 
CBA/Ss (CBA); C3H/HeJ (C3H); C57BL/ 6 (86). Strain A mice are H-
2", CBA and C3H mice are H-2', and 86 mice are H-2". 
Transplantation 
Skin grafting was performed according to the method of Billingham 
(2]. Skin grafts from perinatal or adult donors were full-thickness disks 
or rectangles with areas representing about half the total integument 
of a newborn or late fetal donor. Starting 8 to 10 days after transplan-
tation, we appraised graft sw·vival by visual inspection, often with the 
aid ~fa dissecting microscope. The end point (rejection) was scored as 
the day of complete epithelial breakdown. 
Statistics 
Median survival time (MST), standard deviation, and confidence 
limits were computed according to the method of Litchfield (3]. 
Irradiation. 
In the 86 male-to-female and C3H <-+ CBA systems described below, 
irradiation was performed with a Standard X-ray machine (210 kvp; 15 
ma; 0.5-mm AI filtration; 0.8-mm Cu half-value layer; and focus-to-skin 
distance of 60 em at 160 R/ min) . In the skin-specific (Sk) antigen 
system, irradiation was performed with a 137Cs source (Atomic Energy 
of Canada, Ltd) at about 120 R/ min. 
Cell Suspensions 
These were prepared according to procedw-es described elsewhere 
[ 4,5]. 
Induction of Tolerance 
Suspensions of 20 x 106 spleen and lymph node cells were injected 
into the orbital branches of the anterior facial veins [ 4] of neonatal 
mice (less than 18 hr old) . 
H-2 Typing 
In the Sk.system, chimerism was verified serologically by the stan-
dard assays of hemagglutination (erytluocytes) and cytot.oxicity (leu-
kocytes) (as described in reference 6). Erythrocytes and leukocytes of 
A strain mice inoculated at birth with (A X B6)F, lymphocytes were 
typed positive for H-2" and H-2", thereby confirming the presence of 
H-2"/ H-2" cells of the donor type. 
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TABLE I. Influence of donor age on survival of B6 male-to-female skin grafts" 
Number of 
recipients 
Distribution of graft survival times (days) 
MST'' (days) Donor 
< 14 15-24 25-50 51-75 76-100 > 100 
Adult 101 5 46 45 4 1 25.0 [10]; 24.5 [11] 
Neonatal 77 6 9 6 3 53 (69% "tolerant") 
"Combined data from Billingham, Silvers, and Wilson [10] and S ilvers [11] showing extended survival of neonatal male skin "isografts" on B6 
female recipients. 
" Abbreviation: MST, median survival time. 
RESULTS AND DISCUSSION 
Neonatal Skin Grafts: The H- Y System 
In certain highly inbred mouse strains, especially those with 
the H-2b allele, male tissues are incompatible in female recipi-
ents. For example, in the B6 strain, male-to-female skin grafts 
are uniformly rejected, whereas skin grafts exchanged between 
the other sex combinations (male-to-male, female-to-male, fe-
male-to-female) are uniformly accepted [7). Rejection in this 
case is due to presence in donor tissues of H-Y antigen, a male-
specific cell surface component determined either directly or 
indirectly by genes on the Y chromosome. (H-Y antigen is 
widely conserved among vertebrates, and there is now a per-
suasive body of evidence that the serologically detectable mol-
ecule is the inducer of the mammalian testis [see discussion in 
reference 8).) 
H -Y has been classified as a "weak" antigen; the MSTs ofH-
y -incompatible skin grafts tend to cluster around 25 days; the 
time depends on the size of the grafts and on the site from 
which the donor skin was excised [9). 
In the 1965 study of Billingham, Silvers, and Wilson [10], the 
MST of 71 male B6 skin grafts was 25 days on B6 females; in a 
1968 study [11], the MST of 30 such grafts was 24.5 days. But 
the situation was radically different when the grafts came from 
neonatal donors (less than 24 hr old). In the 1965 study, 19 of 
31 grafts from newborn males (61 %) were "tolerated" (i.e., 
survived throughout the 100-day observation period), and in 
the 1968 study, 34 of 46 grafts from newborn males (75%) were 
tolerated (Table I). It is unlikely that tolerance was due to the 
absence of H-Y antigen in the grafted perinatal tissues. In both 
studies, grafts borne by adult females for more than 100 days 
were rejected when removed and retransplanted to normal 
female hosts, though rather more slowly than "fresh" adult 
male skin isografts (the MST of 23 retransplanted grafts was 36 
days; 2 survived more than 100 days on the secondary hosts 
[11).) Moreover, if it were absence of H-Y antigen that allowed 
long-term survival of neonatal male skin grafts on adult female 
hosts, one might expect adult male skin grafts transplanted 
contralaterally to be rejected by the female host with normal 
or near normal vigor. But failure of the B6 female host to reject 
neonatal male skin isografts was due to a state of unresponsive-
ness induced in the host by the neonatal tissues. In the studies 
cited above, when B6 females bearing neonatal male skin iso-
gra.fts for more than 50 days were challenged on the other side 
of the thorax with adult male skin isografts, fully half of the 
hosts tolerated both grafts. When B6 females were exposed 
simultaneously to contralateral adult and neonatal male skin 
isografts, 23% of the hosts tolerated both grafts. So it seems 
that neonatal male skin grafts release antigen in a "tolerance-
inducing" form. 
Neonatal Shin Grafts: The C3H- CBA System 
C3H and CBA mice are derived from a common stock. Both 
strains are compatible with respect to the MHC; both are H-2k. 
Yet these strains differ with respect to several H genes. 
We found that skin grafts from adult CBA mice were rejected 
by C3H recipients in 12.2 days. Skin grafts from neonatal CBA 
mice were also rejected in 12.2 days [12). However, when C3H 
hosts were exposed to whole-body X-irradiation, a treatment 
known to depress immunologic reactivity, the MST of the 
neonatal CBA skin grafts was increased considerably relative 
TABLE II. Survival of CBA adult and neonatal skin grafts on adult 
male and female C3H recipients exposed to X- rays" 
X-ray Donor No. MST'' ± 95% confidence 
dose (R) mice (days) limits (days) 
None Adult 21 12.2 
Neonate 21 12.2 
100 Adult 10 12.5 
Neonate 11 17.0 
200 Adult 12 16.1 
Neonate 15 20.3 
300 Adult 12 17.2 
Neonate 22 26.2 
400 Adult 13 20.8 
Neonate 16 41.0 
" See Fig 1 and reference 12. 
"Abbreviation: MST, median survival time. 
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FIG 1. Median survival times (MS'l} of neonatal and adul t CBA 
skin grafts on panels of C3H mice that had received graded doses of 
whole-body X-irradiation (see Table 1). Taken from Wachtel and 
Silvers [12]. Reprinted by permission: The Journal of Experimental 
Medicine. 
to the MST of the adult skin grafts (Table II) . At 100 R, the 
MST of the neonatal grafts was increased to 16.1 days, but the 
MST of adult grafts was not increased. At 400 R, the neonatal 
grafts survived for 41 days; the life of the adult grafts was 
increased only slightly, to 21 days (Fig. 1) . 
The disparity between neonatal and adult graft survival was 
striking when CBA mice were used as recipients. The MST of 
adult C3H grafts on 28 CBA recipients was only 16.0 days, but 
many of the C3H neonatal skin grafts survived permanently: 4 
of 19 (21 %) on CBA female hosts and 21 of 27 (78%) on CBA 
male hosts. (Differences in the immunologic reactivity of males 
and females, generally "favoring" females, are known in several 
systems [reviewed in reference 1].) Moreover, the neonatal 
grafts were able to induce a state of unresponsiveness to adult 
C3H skin grafts transplanted 100 days later. Of the 16 CBA 
male recipients that had accepted neonatal C3H skin grafts, all 
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now tolerated adult C3H grafts. In contrast, the 4 CBA females 
that had accepted neonatal grafts now rejected the adult 2nd 
grafts, after 9, 10, 16, and 21 days (Table III). 
Gene dosage effects are recognized for several systems of cell 
surface antigens. Representation of a cell surface antigen on 
heterozygous cells seems to be less than that on corresponding 
homozygous cells (see, for example, references 13,14) . Accord-
ingly, we next grafted (heterozygous) skin from neonatal (CBA 
x C3H)F 1 hybrid mice onto females of the CBA strain. (We 
have seen that 79% of these females reject [homozygous] skin 
grafts from neonatal C3H donors.) Of 26 female CBA mice that 
received (CBA X C3H) neonatal skin grafts, 21 (81%) accepted 
the grafts; 20 of the 21 accepted subsequent adult C3H grafts 
after the neonatal grafts had been in place for 100 days. Thus, 
as in the H-Y system, neonatal skin grafts survive longer than 
adult grafts in the CBA - C3H strain combination, the latter 
involving multiple non-H-2 disparities. In the C3H - CBA 
direction, neonatal skin grafts may induce in their hosts a state 
of unresponsiveness to subsequent (or even simultaneous) adult 
skin grafts. In some situations in which homozygous grafts are 
rejected, heterozygous (F,) grafts may persist and likewise 
induce unresponsiveness to parental strain adult skin grafts. 
Neonatal Shin Grafts: The Sk System 
The Chimaera is a mythological monster, often depicted as 
a composite of lion, goat, and serpent. The chimera of biologists 
is less awesome; it merely represents genetically distinct popu-
lations of cells within the same organism. In immunology, a 
radiation chimera is an animal (for instance, a mouse) that has 
been irradiated (to eliminate immunologically competent host 
lymphoid cells and their precursors) and then "restored" with 
an inoculum of hematopoietic cells from another (genetically 
disparate) animal. A neonatal chimera is an animal that has 
been exposed at birth or shortly thereafter to an inoculum of 
genetically disparate lymphohematopoietic cells. In both situ-
ations, the immunologist creates in the host a state of immu-
nologic "inefficiency" with respect to donor cells-in the former 
case by eliminating immunocompetent (radiosensitive) cells, 
and in the latter case by selecting immature animals unable, by 
virtue of their age, to reject donor cells (sublethal doses of 
irradiation are sometimes employed in establishing neonatal 
chimerism). Thus, chimeric animals contain immunocytes of 
donor origin, and, when the genetic combination is such that 
the donor cells cannot react against host antigens (F,- pru·en-
tal), the result is mutual tolerance. It follows that skin grafts 
from an (Ax B)F 1 donor should survive indefinitely in B hosts 
lethally inadiated and reconstituted with (A X B)F, bone 
manow cells, or in B hosts inoculated "neonatally" with (A X 
B)F1 bone marrow cells, as long as the chimerism is maintained. 
Yet hematopoietic chimerism does not ensure acceptance of 
skin grafts from the donor of the colonizing cells (reviewed in 
references 15,16). For example, B6 mice lethally irradiated and 
then reconstituted with bone marrow cells, spleen cells, or both 
from (B6 X A) or (A X B6)F1 donors often reject subsequent A, 
(B6 X A)F., or (A X B6)F1 skin grafts, even though the recipi-
TOLERANCE-INDUCING PASSENGER CELLS 91 
ents are chimeric with respect to erythrocytes and leukocytes 
of donor origin [15]. Rejection in this system is due to a tissue-
specific differentiation alloantigen (Sk) present in skin (and 
neurectodermal derivatives such as brain) but absent in lymph-
oid cells. Thus, lymphocytes removed from an environment in 
which a particular Sk antigen is expressed gain the capacity to 
react against it and thereby exhibit a manifestly autoimmune 
reaction. There is, of course, the possibility that rejection of Sk 
antigen incompatible skin grafts in radiation chimeras is due to 
survival of a residuum of radiation-resistant hematopoietic stem 
cells of the host, but this possibility should have no bearing on 
the selective expression of Sk antigen since the surviving host 
cells should be tolerant of antigens borne by colonizing lym-
phocytes of the donor in any event. Indeed, Sk antigens are also 
indicated in cases of neonatal chimerism in which donor and 
host cells coexist, for example in B6 mice subjected to sublethal 
doses of X-irradiation (400 to 500 R) and then inoculated within 
24 hr of birth with 20 X 106 lymphocytes from adult (A X B6)F 1 
donors. In the study of Silvers et al [6], these neonatal chimeras 
subsequently rejected skin grafts (transplanted 12 to 14 wk 
after birth of the host) from A strain adult donors, despite 
persistent hematopoietic chimerism, demonstrable by H -2 typ-
ing in erythrocytes and leukocytes. However, the chimeric hosts 
failed to react with equal vigor when neonatal A strain skin 
grafts were used instead of adult skin grafts. Although adult 
grafts were rejected uniformly, 31% of the neonatal grafts were 
accepted by chimeric females, and 64% by chimeric males 
(Table IV). 
In view of the earlier observations in B6 mice and in C3H 
and CBA mice, it was not surprising to find that Sk antigen 
incompatible grafts from neonatal donors could induce in their 
hosts a state of unresponsiveness to subsequent Sk antigen 
incompatible grafts of adult origin. Of 10 chin1eric B6 ~ (A x 
B6)F, mice beru·ing long-term neonatal A strain skin grafts and 
challenged with adult A strain skin grafts, 8 permanently ac-
cepted both. 
Passenger Cells: The H- Y and Sk Systems 
In 1967, David Steinmuller [17] showed that A skin isografts 
from A ~ (A X C3H) neonatal chimeras, i.e., from A mice 
carrying (A X C3H)F, lymphoid cells, could immunize A strain 
recipients against subsequent C3H skin allografts carrying 
antigens in common with the (A X C3H)F 1 inoculum. He 
deduced that (A X C3H) lymphoid cells borne passively within 
the vasculature of the A- A skin isografts were immunogenic 
(see discussion by Steinmuller [18] in this issue). In the litera-
ture there are numerous reports consistent with this view 
(reviewed in references 18,19) , and indeed it is widely accepted 
that "contaminating" passenger leukocytes not only serve as a 
source of sensitizing antigen, but also contribute to the suscep-
tibility of solid-tissue allog1·afts to the host's immune response. 
Are passenger leukocytes involved in the privileged survival 
of neonatal skin g1·afts? Certainly not in the Sk system; by 
definition Sk antigen is not found on the leukocyte membrane. 
Specific tolerance (generally representing extraordinary expo-
TABLE III. Survival of adult and neonatal C3H and F, shin grafts on CBA recipients" 
Recip ient No.(%) MST• Donor 
Sex No. tole ran t (days) 
C3H adult Male and Female 28 16.0 
C3H Neonatal Male 27 21 (78)'" 
Female 19 4 (21)" 17.0 
(CBA x C3H)F, Adult Male and Female 21 1 (5) 19.0 
(CBA x C3H)F 1 Neonatal Female 26 21 (81)'" 
" See reference 12. 
" Abbreviation: MST, median survival time. 
c Of these recipien ts, 16 were chaUenged with a n adult C3H skin graft after 100 days; aU 16 tolerated both grafts. 
'
1 None of these recipients accepted a subsequent adult C3H skin graft. 
' Of these recipients, 20 accepted a subsequent adult C3H skin graft. 
± 95% confidence 
limits (days) 
1.4 
3.1 
1.8 
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TABLE IV. Influence of donor age on survival of Sk antigen-incompatible A strain shin grafts on B6 +-(A X B6)F, chimeric mice" 
Donor 
Recipient Range of graft survival times MST' % hosts 
Sex No. (days) (days) tolerant 
Adult Male 16 13-69 24.0 
Female 13 13-45 13.2 
Neonatal Male 22 15->100 64 
Female 13 15-> 100 31 
"Recipients irradiated (500 R) and inoculated at birth with 20 X 10" (A x B6)F, lymphoid cells. Note the difference in the responses of males 
and females; compare with data in Table III. Taken from Silvers, Wachtel, and Pool [6]. 
"Abbreviation: MST, median survival time. 
sure of the host to antigen) requires, for its persistence, the 
persistence of antigen [20)- If it were passenger leukocytes that 
induced tolerance to a particular skin graft, removal of the graft 
should not affect the tolerant state; on the other hand, if it were 
the intact graft itself that induced tolerance, removal of the 
graft should "break" the tolerant state. It follows that complete 
removal of Sk antigen incompatible neonatal skin grafts before 
exposure of the host to a secondary adult graft should result in 
destruction of the adult grafts. Silvers et al [6] carefully re-
moved 6 neonatal (Sk antigen incompatible) A skin grafts after 
they had been in place for 200 days on their B6 chimeric male 
hosts. When challenged 50 days later with adult A skin grafts, 
the hosts reacted as if they had never "seen" the neonatal 
grafts. The adult grafts were all rejected, and the range of 
survival times (20 to 47 days) approximated that (13 to 69 days) 
observed for similar grafts on naive chimeric male hosts. 
A similar situation was observed in the B6 male-to-female 
system. Excision of long-surviving neonatal B6 male grafts also 
resulted in loss of tolerance. When their neonatal male grafts of 
100 days' standing were removed, 20 adult B6 female hosts 
rejected adult B6 male skin grafts (transplanted 50 days later) 
in an accelerated fashion (a single adult male graft survived for 
>100 days [ll]) : This phenomenon indicated that survival of 
neonatal B6 male skin grafts was not due to the presence of 
passenger leukocytes. To examine the question further, we 
performed several tests [5]: 
Irradiation of the graft: If passenger cells are critical to the 
extended survival of neonatal male B6 skin grafts, selective 
destruction of the passenger cells should prejudice graft sur-
vival. We have pointed out that 850 R of X-irradiation are 
lethal for hematopoietic cells. Accordingly, skin from neonatal 
B6 male mice exposed to 850 R of whole-body X-u-radiation 
was grafted onto a panel of 23 adult B6 females. Skin from 
irradiated B6 neonatal females served as controls. All of the 
female grafts survived permanently on the B6 female hosts; 
65% of the male grafts survived permanently; of these, half 
induced tolerance to subsequent adult male grafts. 
Emigration of passenger cells: There is evidence of extensive 
vascular continuity between skin graft and host within 48 hr of 
transplantation [21]- Within 4 days the circulating lymphocyte 
moiety of a newborn skin graft should therefore be replaced by 
adult cells of host origin. We transplanted neonatal male B6 
skin onto adult male B6 mice and allowed the grafts to remain 
in place for 4 days. At the end of that time, the grafts were 
removed, carefully trimmed, and retransplanted onto adult 
female 'B6 recipients. The procedure did not influence the 
survival of the neonatal male skin grafts (presumably containing 
adult leukocytes; see below). Of 14 grafts so treated, half were 
accepted permanently, whereas 7 of 12 untreated skin g1·afts 
from 4-day-old males were accepted permanently (58%). 
Analysis of chimerism: Adult B6 females bearing long-term 
neonatal male B6 skin grafts evidently are not chimeric. Tissues 
from these tolerant females do not detectably influence the 
response of secondary female hosts to adult male skin grafts. 
With a modified version of the method of Billingham, Silvers, 
and Wilson [10], we exposed B6 adult females to isografts of 
various tissues from B6 females tolerant of neonatal male skin 
grafts, and then to test grafts from adult B6 males. The results 
(Table V) failed to indicate clearly the presence of male lymph-
oid cells in these tissues. (It is perhaps worth pointing out that 
in neonatal female B6 mice contamination of an inoculum of 20 
million B6 female cells with 12,000 male cells produces a state 
of tolerance to H-Y antigens in the hosts [10)-) 
Direct inoculation of leulwcytes: The results described in the 
preceding paragraphs argued against the view that the survival 
of neonatal male B6 skin g1·afts depends on passenger cells, but 
they did not rule out the possibility that passenger cells may 
contribute to the induction of uru-esponsiveness in females 
bearing neonatal male g1·afts. We therefore injected from 1 to 
6 million cells from neonatal B6 male thymus or peripheral 
blood and from 16-day-old fetal B6 male liver subcutaneously 
into B6 females; after 50 days, we challenged the females with 
adult male skin isografts. In all cases the adult male grafts were 
rejected, generally in an accelerated fashion (Table VI). Far 
from rendering their hosts tolerant, the perinatal male leuko-
cytes had sensitized them. Thus, in the B6 male-to-female 
system, passenger leukocytes appear to make little or no con-
tribution to the long-term survival of neonatal male skin grafts, 
or to the induction of tolerance to subsequent adult male skin 
grafts. The situation is radically different, however, in other 
donor-host combinations. 
Passenger Cells: The C3H- CBA System 
Earlier I mentioned that the maintenance of specific toler-
ance depended on the persistence of antigen, and that removal 
of Sk or H-Y incompatible neonatal g1·afts caused loss of toler-
ance in thei.I· hosts. In contrast, removal of the neonatal C3H 
graft did not cause loss of tolerance in CBA hosts. We removed 
C3H neonatal skin grafts of 100 days' standing from 12 adult 
CBA males and, after 50 days, challenged each with an adult 
C3H graft [5]- Of the adult grafts, 2 were rejected in an accel-
erated fashion and 2 were rejected on days 34 and 36; 8 were 
not rejected. 
It seems that the uru-esponsiveness of CBA mice exposed to 
neonatal C3H skin grafts is related to the emig1·ation of passen-
ger leukocytes from the graft vasculature; tolerant CBA mice 
are CBA ~ C3H leukocyte chimeras. This conclusion is borne 
out by evidence from several experiments [5]- * 
Irradiation of the graft: When newborn C3H mice were 
exposed to 850 R of whole-body X-u-radiation just before graft-
ing, skin from these animals did not survive on adult CBA 
recipients, but skin from irradiated newborn C3H mice did 
survive on adult C3H (isogenjc) recipients. In fact, all of 15 
isografts survived permanently, whereas only 1 of 19 (5.3%) 
allografts survived permanently (compare these figures with 
the 78% permanent survival of untreated C3H neonatal skin 
allografts on CBA males). These data suggest that passenger 
cells in the C3H - CBA combination do contribute to the 
survival of neonatal C3H g1·afts unlike passenger cells in the B6 
male ~ B6 female combination. Yet it could be argued that 
• In most of these experiments, C3H mice were used as donors and 
CBA mice were used as recipients because tolerance could be readily 
induced in that direction with neonatal grafts. We prima rily used CBA 
male recipients because they are less likely than females to reject such 
grafts. 
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TABLE V. S urvival of adult male B 6 skin graft s on female B6 mice 
exposed to isografts from tolerant B6 females" 
Isograft t issue'' No. of h osL~ MST ±SO (days) ' 
Lymph node 9 22.0 ± 1.3 
Spleen 7 20.0 ± 1.3 
Thymus 10 22.5 ± 1.2 
Bone m a rrow 4 27.0 ± 1.2 
Skin 18 22.7 ± 1.2 
" See reference 5. 
b Wit h the exception of skin , 40 X 10,; ce Lls from each t issu e of B6 
females bearing neonatal B6 ma le s kin grafts for more than 100 days 
were injected intra peritoneally in to na ive B6 females; t he recipien ts 
were ch a Ll enged 7 days later with s kin from adult B6 males. 
c Con trol median survival t ime (MST), 24.5 days. 
TABLE VI. Effect of subcutaneous inoculation of B6 male fetal, 
neonatal, or adult leulwcytes on the survival of adult male B6 shin 
grafts" in. B6 adult females'' 
No. cells No. Type cells injected injecLed 
(X 10") hosLs 
Neonatal thymus 5 
Adult t h ymus 5 
Neonatal leukocytes 1 
Adult leukocytes 1 
Fetal liver" 6 
Adult liverd 6 
" Transplanted 50 days after inoculation. 
b See reference 5. 
8 
11 
20 
12 
12 
6 
c Abbreviation: M ST, median survival t ime. 
d Liver from a 16-day-old m ale fetus. 
MST''± SD 
(days)'' 
11.0 ± 1.2 
10.0 ± 1.1 
16.3 ± 1.6 
14.5 ± 1.5 
10.3 ± 1.1 
13.2 ± 1.2 
failure of neonatal allograft survival in these experiments was 
not due to elimination of passenger cells, but to a synergistic 
effect of X-inadiation in combination with the normal immune 
response of the host. (Skin allografts from inadiated C3H adults 
also fared poorly on CBA hosts. ) We therefore arranged for a 
less traumatic elimination of graft-borne leukocytes (see next 
paragraph). 
Emigration of passengei· cells. Skin from 17-day-old C3H 
fetuses was isografted to adult C3H mice, allowed to r emain in 
place for 4 days, a nd then removed, cleaned, and allografted to 
a panel of adult male CBA mice. The rationale for these 
experiments was the same as for similar experiments described 
above: vascular connections between tissues of the isograft and 
primary host should promote exchange of blood. Consequently, 
the "neonatal" grafts were expected to carry adult passenger 
cells to the secondary allogeneic host. If passenger cells were 
critical to the life of the neonatal allograft, r ejection should 
ensue. The stratagem worked. Of 24 secondary hosts, only 1 
(4.2%) was unresponsive; the MST of the perinata l C3H grafts 
was 15.1 days (compa1·e this figure with the 16.0-day MST for 
adult C3H skin grafts on CBA recipients). If fetal skin grafts 
acquire circulating leukocytes of the primru·y host, do these 
cells pass into the tissues of the secondary host? Consider a n 
experiment (Fig 2) modeled after the system described in (17). 
Panels of A stra in mice were made chimeric through injections, 
given at birth, of spleen and lymph node cells from adult (C3H 
X A)F, donors. When they were 3 to 6 months old, the A_,_ 
(C3H X A) chimeras were used as primary hosts for skin 
isografts from 17 -day-old fetal A strain donors. After 4 days, 
the grafts were excised and retransplanted (isografted) to a 
panel of 17 hitherto untreated A strain ad ul ts. Seven days later, 
each A strain ad ult received an allograft of C3H skin on the 
other side of its thorax. The C3H grafts were sloughed in 
accelerated fash ion. The 7.8-day MST for these C3H grafts was 
significantly less than the 10.7-day MST for similar grafts on 
"naive" A strain adults. It seems that the seconda1·y hosts were 
immunized against C3H antigens by exposure to passenger cells 
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acquired in the perinatal isografts. By inference, loss of neonatal 
passenger leukocytes is incons istent with survival of neonatal 
C3H grafts on CBA hosts. 
Analysis of chimerism: To determine whether C3H neonatal 
passenger cells colonize CBA hosts, we exposed female adult 
CBA mice to isografts of vru·ious t issues from CBA mice bearing 
neonatal C3H skin grafts for more than 100 days, and then to 
skin grafts from C3H adults. We thought the presence of 
colonizing C3H cells in the CBA isografts would immunize the 
CBA hosts against C3H antigens; this immunization would be 
manifest as a "second-set" (accelerated) r ejection of the C3H 
test grafts. Indeed, the C3H test grafts were rejected acutely 
(Table VII) , a n indication that t heir hosts had been immunized 
by isog:rafts putatively bearing C3H passenger cells . Yet the 
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FIG 2. Experimen tal protocol for detect ion of acquired "chimeric" 
passenger cells in a perinatal A strain skin graft [5, 17]. SPL, spleen ; 
LN, lymph node. 
TABLE VII. Survival of adult C3H shin grafts on. adult CBA m.ice 
exposed to isografts from tolera.nt CBA mice" 
lsogru fL tissue' 
Lymph node 
Spleen 
Thymus 
Skin 
No. hosLs 
8 
11 
8 
22 
MST ±SO 
(days) ' 
7.5 ± 1.3 
7.5 ± 1.1 
9.0 ± 1.4 
11.2 ± 1.3 
" Beru·ing neonatal C3H skin grafts> 100 days. See reference 5. 
1
' Cells (40 X 10") of designated tissu e (except skin ) from to lerant 
CBA males were injected intraperitoneaUy in to naive CBA male and 
female recipients; t h e r ecipients were challenged 7 days later with skin 
from adult C3H mice. 
,. Control m edian survival t ime (MST) , 16.0 days (see Table III). 
TABLE VIII. E ffect of subcutaneous inoculation of C3H (eta.l, 
neonatal, or adult leulwcytes on the survival of C3H adult shin 
grafts" in adult CBA recipients' 
Type ce lls injecLed 
NeonaLal Lhymus 
Ad uiL Lhymus 
NeonaLal leukocyLes 
AduiL leukocytes 
Fetal liver" 
Adult liver 
NconaLal spleen 
No. cells in- No. jected (X 10';) hosts 
5 16 
5 II 
19 
12 
6 
6 
12 
" T o·unsplanted 50 days after inoculation. 
'See reference 5. 
,. AbbreviaLion: MST, median survival Lime. 
"Liver from 14- Lo 15-day-old feLuses. 
MST" ± SD No. (%) hosLs (days) tolerant 
11.0 ± 1.3 I (6) 
10.0 ± 1.1 
12.0 ± 1.6 2 (I I ) 
9.1 ± 1.1 
10.0 ± 1.0 
9.4 ± 1.1 
10.0 ± 2.7 
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data may have been an indication that antigens were seques-
tered in CBA isologous passenger cells in such a way that 
presentation to the secondary hosts rendered them immune. 
One might argue, moreover, that accelerated rejection in this 
system reflected passive transfer of immune cells from tolerant 
animals [22], although in other tests we could not transfer 
immunity into naive CBA mice by exposing them to 40 X 106 
thymus cells or to skin grafts from sensitized CBA mice, i.e., 
CBA mice that had rejected C3H skin grafts [5]. 
Direct inoculation of leukocytes: To determine whether leu-
kocytes acting alone can induce tolerance in the C3H - CBA 
system, we exposed adult CBA mice to subcutaneous injections 
of leukocytes from the thymuses, peripheral blood, and spleens 
of neonatal C3H mice and from the livers of fetal C3H mice; 
the recipients received grafts of adult C3H skin 50 days after 
inoculation. As shown in Table VIII, CBA males exposed to 
leukocytes of C3H adult, neonatal, or fetal origin were generally 
sensitized and rejected their C3H test grafts in an accelerated 
fashion; 3 CBA males failed altogether to reject the grafts. The 
fact that unresponsiveness was secondary to exposure to circu-
lating leukocytes in 2 cases indicates that these cells need not 
be carried in a skin graft to influence the host (though they are 
evidently more efficient "tolerance inducers" when neonatal 
skin grafts serve as their vehicle). 
The results described above are consistent with the view that 
passenger cells may influence the immune response of the host 
toward solid-tissue grafts and with the view that these cells 
may actually promote a state of tolerance in certain combina-
tions involving neonatal tissues. Thus, the extended survival of 
neonatal C3H skin grafts seems dependent on survival and 
emigration of the leukocyte moiety. It is not clear whether 
passenger leukocytes also influence the extended survival of 
reciprocal CBA neonatal skin grafts exhibited in irradiated C3H 
recipients. 
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